Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

Date: Tuesday 17 - Thursday 19 November 2020
Venue: Novotel Paris Tour Eiffel, France

The 1st ESH Translational Research Conference on Chronic Lymphocytic Leukaemia (CLL) proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international audience of biologists and clinicians, including those still in-training.

This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of Chronic Lymphocytic Leukaemia (CLL). New data will be presented and spirited debates on how best to apply these insights to the future of CLL therapy are expected.

Emphasis will be placed on critical discussion, including in small groups. Further to the plenary sessions, the programme includes informal thematic break-out sessions and mentored poster walks.

Posters and Brief Oral Communications:
Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline Friday 10 January 2020

This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives.
  • An emphasis on in-depth scientific discussion
  • Opportunities for informal face-to-face scientific interaction with global authorities in the field.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD) 
  • PhD candidates and clinical residents still in-training

Learning Objectives:

  • Understand recent advances in elucidating the pathogenesis of CLL
  • Describe recent data on therapeutic regimens for CLL
  • Understand emerging data on mechanisms of resistance to targeted agents in CLL
  • Understand the debate about how best to optimise CLL therapy in the future


  • The genomic and epigenomic landscape of CLL and clinical consequences
  • The role of BCR activation and signalling for CLL
  • Therapeutic options for CLL
  • Long term follow-up of clinical trials versus real world data (outside clinical trials data-oct)
  • The increasing role of the leukaemic microenvironment
  • Therapeutic options: the use of cellular and non-cellular immunotherapies in CLL
  • Efficacy through safety
  • Clonal heterogeneity, clonal evolution and mechanisms of drug resistance
  • Contrasting therapeutic concepts

The programme will include:

  • Plenary Sessions
  • Simultaneous Meet the Expert Sessions
  • Panel Discussions
  • Poster Walks

For further information and to register your place please visit the conference website or email Camille Dufour

External Events

Nov 20
Jan 21
Feb 21
Mar 21
May 22
November 4th 2020
BSBMTCT Education Day
An update day for anyone working in the field of Bone Marrow Transplantation. Suitable for Transplant Directors, Consult…
November 6th 2020
How to Diagnose and Treat: Lymphoma
Chairs: Christian Buske, Catherine Thieblemont, Anas Younes
November 6th 2020
Post-transplant Managing Quality of Life Symposium…
This symposium will highlight the importance of a multidisciplinary approach for improving patients Quality of Life post…
November 11th 2020
UKMF Autumn Day
The theme of this virtual meeting is Accelerating Research: Better Trial Designs, Better Therapies. Suitable for Consult…
November 12th 2020
UKFHD 50th Academic Meeting
An update in aspects of Haemoglobin Disorders suitable for Consultants, Trainees, Nurses, Data Coordinators, Midwives, S…
November 13th 2020
Translational Research Conference: Bone Marrow Fai…
Chairs: Tim Brümmendorf, Carlo Dufour, Inderjeet Dokal, Régis Peffault de la Tour, Marc H.G.P Raaijmakers, Neal Young
November 17th 2020
1st Translational Research Conference: Chronic Lym…
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek
November 17th 2020
Current Thinking in Haematological Malignancies -…
This meeting will provide attendees with updates in current issues within the management of diseases affecting haematolo…
November 18th 2020
A User Guide to Cancer Immunotherapy
This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-me…
November 23rd 2020
Introduction to Haematology Care
This study day will provide a basic understanding of caring for haematology patients and expand knowledge on the disease…
November 24th 2020
The Royal Marsden Haemato-Oncology Study Day
This study day is aimed at healthcare professionals involved in the treatment of patients with haematological cancers, p…
November 26th 2020
Transplant Complications and GVHD
Updates in transplant complications and GVHD suitable for any member of the BMT team
November 26th 2020
Advances in Transfusion Medicine
There are exciting ongoing developments in transfusion medicine and science with high quality research supporting eviden…
November 27th 2020
HMDS Annual Haematopathology Update Day
The study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferation…
November 27th 2020
Current Thinking in Haematological Malignancies -…
This programme is designed to combine high calibre lectures and interactive discussions to provide an educational opport…
November 27th 2020
Current Thinking in Haematological Malignancies in…
High calibre lectures and interactive discussions. Suitable for consultants, trainees, nurses, pharmacists,scientists an…
January 28th 2021
7th Translational Research Conference: Myelodyspla…
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres
February 2nd 2021
Targeted Treatments for Haematological Cancers
This course describes the unique cellular and genetic features of haematological cancers and covers a diverse range of t…
March 11th 2021
Symposium on the contributions by the Anthony Nola…
An outstanding symposium for BMT and future of haematological malignancies in innovative cell therapies.
May 13th 2022
9th Translational Research Conference: Myeloprolif…
Chairs: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi